Growth hormone replacement in patients with non-functioning pituitary adenoma treated solely by surgery is not associated with increased risk of tumour recurrence.
Background: Subjects with non-functioning pituitary adenomas (NFAs) frequently develop growth hormone deficiency due to tumour expansion or as a consequence of tumour therapy. The safety of growth hormone replacement (GHR) in these individuals remains unclear. Objective: To assess the effect of GHR...
| Main Authors: | , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2008
|